[99mtc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 2, 2003, Pages 247-258

  Nock, Berthold ^a   Nikolopoulou, Anastasia ^a   Chiotellis, Efstratios ^b   Loudos, George ^c   Maintas, Dimitrios ^d   Reubi, Jean Claude ^e   Maina, Theodosia ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^d Institute of Isotopic Studies   (Greece)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

99mTc; Bombesin; Gastrin releasing peptide; Tetraamine chelator; Tumour imaging

Indexed keywords

BOMBESIN DERIVATIVE; DEMOBENSIN 1 TECHNETIUM TC 99M; G PROTEIN COUPLED RECEPTOR; GASTRIN RELEASING PEPTIDE RECEPTOR; UNCLASSIFIED DRUG; BOMBESIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GASTRIN RELEASING PEPTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M DEMOBESIN 1; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG UPTAKE; HUMAN; HUMAN CELL; INJECTION; KIDNEY METABOLISM; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; PROSTATE ADENOCARCINOMA; TARGET ORGAN; TUMOR SCINTISCANNING; TUMOR XENOGRAFT; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CANCER TRANSPLANTATION; CELL CULTURE; CELL MEMBRANE; COMPARATIVE STUDY; EVALUATION; FEMALE; ISOTOPE LABELING; KIDNEY; LIVER; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; PROTEIN BINDING; SCINTISCANNING; SKELETAL MUSCLE; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; BOMBESIN; CELL MEMBRANE; FEMALE; GASTRIN-RELEASING PEPTIDE; HUMANS; ISOTOPE LABELING; KIDNEY; LIVER; MALE; METABOLIC CLEARANCE RATE; MUSCLE, SKELETAL; NEOPLASM TRANSPLANTATION; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PROSTATIC NEOPLASMS; PROTEIN BINDING; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0038579396     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-1040-x     Document Type: Article

References (57)

1. Anastasi A, Erspamer V, Bucci M. Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experimentia 1971; 34:5-30.
2. Erspamer V. Discovery, isolation, and characterization of bombesin-like peptides. Ann N Y Acad Sci 1988; 547:3-9.
3. Delle Fave G, Annibale B, De Magistris L, Severi C, Bruzzone R, Puoti M, Melchiori P, Torsoli A, Erspamer V. Bombesin effects on human GI functions. Peptides 1985; 6:113-116.
4. Bruzzone R, Tamburanno G, Lala A, Mauceri M, Annibale B, Severi C, Magistris L, Leonetti F, Delle Fave G. Effect of bombesin on plasma insulin, pancreatic glucagon and gut glucagon in man. J Clin Endocrinol Metab 1983; 56:643-647.
5. Kroog GS, Jensen RT, Battey JF. Mammalian bombesin receptors. Med Res Rev 1995; 15:389-417.
6. McDonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 1979; 90:227-233.
7. Naldini L, Cirillo D, Moody TW, Comoglio PM, Schlessinger J, Kris R. Solubilization of the receptor for the neuropeptide gastrin-releasing peptide (bombesin) with functional ligand binding properties. Biochemistry 1990; 29:5153-5160.
8. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER. Biology of disease. Gastrin releasing peptide (mammalian peptide) gene expression in health and disease. Lab Invest 1988; 59:5-24.
9. Preston SR, Miller GV, Primrose JN. Bombesin-like peptides and cancer. Crit Rev Oncol Hematol 1996; 23:225-238.
10. Rozengurt E, Sinnett-Smith J. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci USA 1983; 80:2936-2940.
11. Rozengurt E. Bombesin stimulation of mitogenesis. Specific receptors, signal transduction and early events. Am Rev Respir Dis 1990; 142:S11-S15.
12. Cuttita F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985; 316:823-826.
13. Carney DN, Cuttita F, Moody TW, Minna JD. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res 1987; 47:721-725.
14. Nelson J, Donelly M, Walker B, Gray J, Shaw C, Murphy RF. Bombesin stimulates proliferation of human breast cancer cells in culture. Br J Cancer 1991; 63:933-936.
15. Yano T, Pinski J, Groot K, Schally AV. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res 1992; 52:4545-4547.
16. Giachetti S, Gauville C, de Cremoux P, Bertin L, Berthon P, Abita JP, Cuttita F, Calvo F. Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J Cancer 1990; 46:292-298.
17. Bologna MC, Festuccia C, Muzi P, Biordi L, Ciomei M. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989; 63:1714-1720.
18. Nagakawa O, Ogasawara M, Fujii H, Murakami K, Murata J, Fuse H, Saiki I. Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. Cancer Lett 1998; 133:27-33.
19. Aprikian AG, Tremblay L, Han K, Chevalier S. Bombesin stimulates the motility of human prostate carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J Cancer 1997; 72:498-504.
20. Pinski J, Schally AV, Halmos G, Szepeshazi K. Effect of somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on growth of PC-3 human prostate cancer xenografts in nude mice. Int J Cancer 1993; 55:963-967.
21. Aprikian AG, Han K, Chevalier S, Bazinet M, Viallet J. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. J Mol Endocrinol 1996; 16:297-306.
22. 4)bombesin by tumor cells. Prostate 1994; 25:29-38.
23. Frucht H, Dazdar AF, Park JA, Oie H, Jensen RT. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992; 52:1114-1122.
24. Guinee Jr DG, Fishback NF, Koss MN, Abbondanzo SL, Travis WD. The spectrum of immunohistochemical staining of small cell lung carcinoma in specimens from transbronchial and open lung-biopsies. Am J Clin Pathol 1994; 102:406-414.
25. Toi-Scott M, Jones CL, Kane MA. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. Lung Cancer 1996; 15:341-354.
26. Bartholdi MF, Wu JM, Pu H, Troncoso P, Eden PA, Feldman RI. In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma. Int J Cancer 1998; 79:82-90.
27. Markwalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 1999; 59:1152-1159.
28. Sun BD, Halmos G, Schally AV, Wang XE, Martinez M. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate 2000; 42:295-303.
29. Pagani A, Papotti M, Sanfilippo B, Bussolati G. Expression of the gastrin-releasing peptide gene in carcinomas of the breast. Int J Cancer 1991; 47:371-375.
30. Halmos G, Wittliff JL, Schally AV. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Cancer Res 1995; 55:280-287.
31. Gugger M, Reubi J. Gastrin releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol 1999; 155:2067-2076.
32. Reubi JC, Gugger M, Wasser B. Coexpressed peptide receptors in breast cancers as molecular basis for in vivo multireceptor tumor targeting. Eur J Nucl Med 2002, 29:855-862.
33. Nyeki O, Rill A, Schon I, Schrett J, Bartha L, Nagy J. Synthesis of peptide and pseudo-peptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells. J Pept Sci 1998; 4:486-495.
34. Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K, Cai RZ. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095. Eur J Cancer 1998; 34:710-717.
35. 6)-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Prostate 1992; 20:269-280.
36. Nagy A, Armatis P, Cai R-Z, Szepeshazi K, Halmos G, Schally AV. Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc Natl Acad Sci USA 1997; 94:652-656.
37. Schally AV, Nagy A. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumours. Eur J Endocrinol 1999; 141:1-14.
38. Breeman WAP, de Jong M, Kwekkeboom DJ, Valkema R, Bakker WH, Kooij PPM, Visser TJ, Krenning EP. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 2001; 28:1421-1429.
39. Breeman WAP, Hofland LJ, de Jong M, Bernard BF, Srinivasan A, Kwekkeboom DJ, Visser TJ, Krenning EP. Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy. Int J Cancer 1999; 81:658-665.
40. Baidoo KE, Lin KS, Zhan Y, Finley P, Scheffel U, Wagner HN Jr. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. Bioconjugate Chem 1998; 9:218-225.
41. Hoffman TJ, Simpson SD, Smith CJ, Simmons J, Sieckman GL, Higginbotham C, Eshima D, Volkert W, Thornback HS. Accumulation and retention of Tc-99m RP527 by GRP receptor expressing tumors in SCID mice. J Nucl Med 1999; 40:104P.
42. Van de Wiele C, Dumont F, Broecke RV, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thornback J, Slegers G, Dierckx RA. Technetium-99m RP527, a GRP analogue for visualization of GRP receptor-expressing malignancies: a feasibility study. Eur J Nucl Med 2000; 27:1694-1699.
43. Van de Wiele C, Dumont F, Van Belle S, Slegers G, Peers SH, Dierckx RA. Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging? Nucl Med Commun 2001; 22:5-15.
44. 99mTc-Labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent. Bioconjugate Chem 1999; 10:254-260.
45. 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nucl Med Biol 2002; 29:553-560.
46. 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjugate Chem 2002; 13:599-604.
47. Safavy A, Khazeli MB, Qin H, Buchsbaum DJ. Synthesis of bombesin analogues for radiolabeling with rhenium-188. Cancer 1997; 80:2354-2359.
48. +. Inorg Chem 1982; 21:2037-2040.
49. +. Inorg Chem 1988; 27:4127-4130.
50. 50s for cellular secretion and growth approaching the picomolar region. In: Rivier JE, Marshall GR, eds. Peptides - chemistry, structure and biology. Leiden: ESCOM; 1990:65-67.
51. Wang, LH, Coy DH, Taylor JE, Jiang NY, Moreau JP, Huang SC, Frucht H, Haffar BM, Jensen RT. Des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. J Biol Chem 1990; 265:15695-15703.
52. 3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results. Eur J Nucl Med 2002; 29:742-753.
53. Mantey S, Frucht H, Coy DH, Jensen RT. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mol Pharmacol 1993; 43:762-774.
54. Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-Tyr(6),beta-Ala(11),Phe(13),NLE(14)]bombesin(6-14). Clin Cancer Res 2002; 8:1139-1146.
55. Fleischmann A, Läderach U, Friess H, Buechler M, Reubi JC. Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab Invest 2000; 80:1807-1817.
56. Moran TH, Moody TW, Hostetler AM, Robinson PH, Goldrich M, McHugh PR. Distribution of bombesin binding sites in the rat gastrointestinal tract. Peptides 1988; 9:643-649.
57. Jensen RT, Moody T, Pert C, Rivier JE, Gardner JD. Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A 1978; 75:6239-6243.